138 related articles for article (PubMed ID: 8213422)
1. Torsades de pointes with Almokalant, a new class III antiarrhythmic drug.
Wiesfeld AC; Crijns HJ; Bergstrand RH; Almgren O; Hillege HL; Lie KI
Am Heart J; 1993 Oct; 126(4):1008-11. PubMed ID: 8213422
[No Abstract] [Full Text] [Related]
2. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
[TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.
Houltz B; Darpö B; Edvardsson N; Blomström P; Brachmann J; Crijns HJ; Jensen SM; Svernhage E; Vallin H; Swedberg K
Pacing Clin Electrophysiol; 1998 May; 21(5):1044-57. PubMed ID: 9604236
[TBL] [Abstract][Full Text] [Related]
4. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Farkas A; Leprán I; Papp JG
J Cardiovasc Pharmacol; 2002 Feb; 39(2):287-97. PubMed ID: 11791015
[TBL] [Abstract][Full Text] [Related]
5. Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome.
Hallman K; Carlsson L
Pharmacol Toxicol; 1995 Oct; 77(4):250-4. PubMed ID: 8577635
[TBL] [Abstract][Full Text] [Related]
6. Torsades de pointes induced by transesophageal atrial stimulation after administration of almokalant.
Darpö B; Allared M; Edvardsson N
Int J Cardiol; 1996 Mar; 53(3):311-3. PubMed ID: 8793587
[TBL] [Abstract][Full Text] [Related]
7. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
Makai A; Rudas L; Liszkai G; Fazekas T
Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.
Badshah A; Mirza B; Janjua M; Nair R; Steinman RT; Cotant JF
Hellenic J Cardiol; 2009; 50(3):224-6. PubMed ID: 19465366
[TBL] [Abstract][Full Text] [Related]
9. Physiological and pathological responses of TU waves to class Ia antiarrhythmic drugs.
Maruyama T; Ohe T; Kurita T; Aihara N; Shimizu W
Eur Heart J; 1995 May; 16(5):667-73. PubMed ID: 7588899
[TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
Skanes AC; Morton BC; Green MS; Tang AS
Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
[TBL] [Abstract][Full Text] [Related]
11. Differences in corrected QT intervals at minimal and maximal heart rate may identify patients at risk for torsades de pointes during treatment with antiarrhythmic drugs.
Buckingham TA; Bhutto ZR; Telfer EA; Zbilut J
J Cardiovasc Electrophysiol; 1994 May; 5(5):408-11. PubMed ID: 8055145
[TBL] [Abstract][Full Text] [Related]
12. Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias.
Wiesfeld AC; Crijns HJ; Tobé TJ; Almgren O; Bergstrand RH; Aberg J; Haaksma J; Lie KI
Am J Cardiol; 1992 Oct; 70(11):990-6. PubMed ID: 1384304
[TBL] [Abstract][Full Text] [Related]
13. ECG Diagnosis: Ibutilide-induced Torsade de Pointes.
Le DD; Levis JT; Lugovskaya N; Vinson DR
Perm J; 2019; 23():. PubMed ID: 30939273
[No Abstract] [Full Text] [Related]
14. Two cases of torsades de pointes caused by sotalol therapy.
Cammu G; Geelen P; Baetens P; De Vos J; Demeyer I
Resuscitation; 1999 Jan; 40(1):49-51. PubMed ID: 10321848
[No Abstract] [Full Text] [Related]
15. Torsade de pointes occurring early during oral amiodarone treatment.
Faggiano P; Gardini A; D'Aloia A; Benedini G; Giordano A
Int J Cardiol; 1996 Jul; 55(2):205-8. PubMed ID: 8842793
[TBL] [Abstract][Full Text] [Related]
16. Early proarrhythmia during intravenous amiodarone treatment.
Tomcsányi J; Merkely B; Tenczer J; Papp L; Karlócai K
Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):968-70. PubMed ID: 10392400
[TBL] [Abstract][Full Text] [Related]
17. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
[TBL] [Abstract][Full Text] [Related]
18. [Conversion to sinus rhythm].
Brunckhorst CB
Praxis (Bern 1994); 2006 Feb; 95(7):247-8. PubMed ID: 16524116
[No Abstract] [Full Text] [Related]
19. Attenuation of proarrhythmias related to delayed repolarization by low-dose lidocaine in the anesthetized rabbit.
Carlsson L; Drews L; Duker G; Schiller-Linhardt G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1076-80. PubMed ID: 8263767
[TBL] [Abstract][Full Text] [Related]
20. Tridimensional activation patterns of acquired torsade-de-pointes tachycardias in dogs with chronic AV-block.
Schreiner KD; Voss F; Senges JC; Becker R; Kraft P; Bauer A; Kelemen K; Kuebler W; Vos MA; Schoels W
Basic Res Cardiol; 2004 Jul; 99(4):288-98. PubMed ID: 15221347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
